Circulating cardiovascular biomarkers in motion: redefining cardiovascular risk with dynamic prediction - Takeaways - MDSpire

Circulating cardiovascular biomarkers in motion: redefining cardiovascular risk with dynamic prediction

  • By

  • Marie de Bakker

  • Becky Gordon

  • Anoop S V Shah

  • Eric Boersma

  • Dorien M Kimenai

  • December 8, 2025

  • 0 min

Share

  • 1

    Current cardiovascular risk estimation systems are suboptimal and require novel strategies for improved personalization and accuracy.

  • 2

    Circulating biomarkers like C-reactive protein and cardiac troponins can enhance cardiovascular risk prediction when integrated into dynamic models.

  • 3

    Dynamic risk prediction approaches, such as joint modeling, can better capture the complexities of cardiovascular disease development over time.

  • 4

    Future research should focus on developing multi-marker dynamic risk prediction models and standardizing methodologies for performance comparison.

  • 5

    Optimizing screening intervals through a biomarker-driven approach may improve individualization of primary cardiovascular prevention strategies.

Original Source(s)

Circulating cardiovascular biomarkers in motion: redefining cardiovascular risk with dynamic prediction

  • by Marie de Bakker, Becky Gordon, Anoop S V Shah, Eric Boersma, Dorien M Kimenai

  • December 8, 2025

Related Content

Complete revascularization and heart failure risk in acute coronary syndrome across the ejection fraction spectrum: focus on LVEF-dependent effects

Heterogeneous benefit of early sacubitril/valsartan initiation after PCI in elderly patients with left ventricular dysfunction: myocardial recovery and mid-term cardiovascular outcomes

Analysis of factors associated with cognitive impairment in elderly patients hospitalized with chronic heart failure